Biotechnology News

December 5, 2012

ST. LOUIS--(BUSINESS WIRE)--Plexxikon selects D360 for scientific data access, data mining, and analysis; enables researchers to easily query and analyze biological assay and chemical registration data from a single dashboard.

December 5, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only The management of bleeding associated with the novel oral anticoagulants is one of the topics of interest at this year’s annual meeting of the American Society...

December 5, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles Chief Information Officer (CIO) Richard Thomas has been named one of Computerworld's Premier 100 IT Leaders for 2013.

December 5, 2012

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies, today reported preliminary data...

December 5, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--PharmaVigilant released I-Accountability, a drug accountability system that efficiently tracks and controls drug inventory and randomization, with access to inventory status through user's smartphone

December 5, 2012

NASHVILLE, Tenn.--(BUSINESS WIRE)--SCRI researchers author 26 clinical studies accepted for presentation at ASH Meeting in Atlanta December 8-11, including 13 oral and 13 poster presentations.

December 5, 2012

BOSTON--(BUSINESS WIRE)--With pharma moving away from the all-in-one model, companies need to develop more products faster. To succeed, they need to identify outside partners in areas such as formulation & delivery, says Lux.

December 5, 2012

PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--VGTI Florida Announces Catherine Vorwald, New Director of Business Development

December 5, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced that the Company has developed a new next-generation sequencing (NGS) assay for the TP53 gene (encoding the p53...

December 5, 2012

VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that Peyton R. Howell has been named Senior Vice President, AmerisourceBergen Corporation and President, Global Sourcing and Manufacturer Relations,...

December 5, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Present Corporate Update at Oppenheimer 23rd Annual Healthcare Conference in New York City on December 12th.

December 5, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi today announced that dosing with their anti-scarring drug, RXI-109, for the management of surgical and hypertrophic scars and keloids has been initiated.

December 5, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Target Amarantus Wins MANF Patent Challenge in Europe

December 5, 2012

PARIS--(BUSINESS WIRE)--A striking association has recently emerged between weight at birth and health in adulthood: adults who had low birth weights are more prone to develop a range of diseases including cardio-vascular disease, type 2 diabetes...

December 4, 2012

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) announced today that it has received correspondence from the Chief Scientific Officer of the Center for Devices and Radiological Health of the U.S. FDA upholding the non-...

December 4, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ) today provided an update regarding the submissions of arbitration-related costs by Atomic Energy of Canada Limited (AECL) associated with Nordion’s arbitration with AECL over...

December 4, 2012

NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb Announces Dividend Increase

December 4, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--REXAHN PHARMACEUTICALS, INC. (NYSE MKT: RNN) announced today the closing of its previously announced underwritten public offering of 19,130,435 units and a partial exercise of the over-allotment option by the...

December 4, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that it has achieved its second development candidate in its animal health collaboration with Eli Lilly and Company (Lilly). Anacor’s research collaboration...

December 4, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per ordinary share. The dividend is payable on December 27, 2012, to shareholders of record as of the...

December 4, 2012

PROVIDENCE, R.I.--(BUSINESS WIRE)--Tech Collective’s second annual STEM in the Middle workshop and career expo aims to increase STEM awareness, interest, and participation at a critical time in students’ education.

December 4, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced the presentation of important new data from studies of FASLODEX® (fulvestrant) Injection at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium taking place from 4-8...

December 4, 2012

PARIS--(BUSINESS WIRE)--The international jury under the presidency of Prof. Albert Galaburda (Harvard Medical School, Boston, USA) awarded on November 27th, 2012 the 21th Jean-Louis Signoret Neuropsychology Prize of the Fondation Ipsen (20.000...

December 4, 2012

SALT LAKE CITY--(BUSINESS WIRE)--Catheter Connections announces that the USPTO has issued a Notice of Allowance for a patent that broadly covers the Company’s DualCap® technology for disinfecting IV tubing end connectors.

December 4, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A new Cutting Edge Information finds affiliate market access teams have valuable input to launch strategy

December 4, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--MichBio, the biosciences industry association in Michigan, joined U.S. Food & Drug Administration (FDA) Commissioner Dr. Margaret Hamburg, FDA Center for Medical Device & Radiologic Health (CDRH)...

December 4, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the pioneering leader in metabolomics-driven biomarker discovery and analysis, announced today that it has renewed a multi-year agreement with Syngenta, a world leading global...

December 4, 2012

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) announced that its Board of Directors today declared an accelerated cash dividend of $0.19 per share payable on December 24, 2012 to shareholders of record on...

December 4, 2012

ACTON, Mass.--(BUSINESS WIRE)--Cognoptix exclusively licenses Alzheimer’s-detection technology from the University of California at San Diego: markers to diagnose
Alzheimer’s

December 4, 2012

BALTIMORE--(BUSINESS WIRE)--Profectus BioSciences announced that a phase 1 study demonstrated the safety and immunogenicity of its recombinant vesicular stomatitis virus (rVSV)-vectored HIV vaccine.

December 4, 2012

FARMINGTON, Conn.--(BUSINESS WIRE)--KCI's Graftjacket® RTM has been shown to help achieve wound closure in diabetic foot ulcers with a single application, in most cases*.

December 4, 2012

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, has entered into a definitive agreement to sell 35 million shares of its common stock at a price per share of $0.30 in a registered direct offering...

December 4, 2012

SAN DIEGO--(BUSINESS WIRE)--MedImpact now offers patient-focused specialty pharmacy management programs in hemophilia and multiple sclerosis designed for population management.

December 4, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Dorsey & Whitney Adds Patent Veteran Scott Smith as Partner in Palo Alto Office

December 4, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, Ph.D. will provide an...

December 4, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Vascular Closure Systems, Inc. Announces the Completion of the First in Human (FIH) Clinical Trial of the 6 Fr. / 7 Fr. FastSeal® Bioabsorbable Vascular Access Closure System - 100% Successful Results

December 4, 2012

LARKSPUR, Calif.--(BUSINESS WIRE)--Bay-area based BioCision raises $2.5 million in growth financing.

December 4, 2012

PALO ALTO, Calif. & EMERYVILLE, Calif.--(BUSINESS WIRE)--Open Monoclonal Technology, Inc. (OMT) and Crystal Bioscience, Inc. (Crystal) today announced a strategic alliance where OMT will access Crystal’s deep antibody screening technology,...

December 4, 2012

DURHAM, N.C.--(BUSINESS WIRE)--Cenduit LLC has introduced a new study simulation and forecasting service that will enable clinical trial sites to better plan and control supplies for their patients.

December 4, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the entry of seven new agents into the Non-Small-Cell Lung Cancer (NSCLC) drug...

December 4, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Global Health Partner (STO:GHP) today won the “Best Annual Report 2011” prize. The prize is awarded by NASDAQ OMX and GHP won in the Small Cap category. NASDAQ OMX’s citation for the prize was...

December 4, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A survey of US drug companies found that 88% have market access teams actively involved in Phase 2 trials, according to Cutting Edge Information.

December 4, 2012

BERLIN--(BUSINESS WIRE)--NOXXON Pharma announces the treatment of the first patients in a Phase IIa clinical trial of its anti-hepcidin Spiegelmer® NOX-H94 to treat anemia associated with chronic disease.

December 4, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus has signed a 2-year purchase agreement with two regional Swiss Red Cross Blood Services for deployment of the INTERCEPT Blood System for plasma.

December 4, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will be providing a detailed review of its business model and growth strategy, along with introducing financial guidance for 2013 and 2014, during its Analyst Day...

December 4, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--New Clinical Data Highlighting Foundation Medicine’s Next-Generation Sequencing Analysis in Breast Cancer to be Presented at SABCS

December 4, 2012

MALVERN, Pa.--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc, a privately held, clinical-stage biotechnology company developing novel drugs to treat metabolic and cardiovascular diseases, announced today that Jonathan P. Mow has been appointed...

December 4, 2012

BURLINGTON, Mass. & BICESTER, England--(BUSINESS WIRE)--Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced today that it acquired Abacus International, a...